Zobrazeno 1 - 10
of 16
pro vyhledávání: '"François R. Girardin"'
Autor:
Paul Thoueille, Susana Alves Saldanha, Fabian Schaller, Eva Choong, Aline Munting, Matthias Cavassini, Dominique Braun, Huldrych F. Günthard, Katharina Kusejko, Bernard Surial, Hansjakob Furrer, Andri Rauch, Mathieu Rougemont, Pilar Ustero, Alexandra Calmy, Marcel Stöckle, Catia Marzolini, Caroline Di Benedetto, Enos Bernasconi, Patrick Schmid, Rein Jan Piso, Pascal Andre, François R. Girardin, Monia Guidi, Thierry Buclin, Laurent A. Decosterd
Publikováno v:
The Lancet Regional Health. Europe, Vol 36, Iss , Pp 100793- (2024)
Summary: Background: The efficacy and tolerability of long-acting cabotegravir and rilpivirine were demonstrated in Phase III trials. However, low concentrations combined with other risk factors have been associated with an increased risk of virologi
Externí odkaz:
https://doaj.org/article/6380ec40d9d94ba48ce0923cbe387561
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/5e593dcc614646208055935b8f8befa8
Autor:
François R. Girardin, Anna Nicolet, Oriol Bestard, Carmen Lefaucheur, Klemens Budde, Fabian Halleck, Sophie Brouard, Magali Giral, Pierre-Antoine Gourraud, Béatrice Horcholle, Jean Villard, Joachim Marti, Alexandre Loupy
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Patient-Reported Outcomes (PRO) integrate a wide range of holistic dimensions that arenot captured within clinical outcomes. Particularly, from induction treatment to maintenance therapy, patient quality-of-life (QoL) of kidney transpla
Externí odkaz:
https://doaj.org/article/2e6caf2f781240f581c2326e49931e5f
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The identification of pharmacogenetic factors that increase the susceptibility to clozapine-induced agranulocytosis or granulocytopenia (CIAG) has received increasing interest. The SLCO1B3-SCLO1B7 variant (rs149104283) and single amino acid changes i
Externí odkaz:
https://doaj.org/article/fee9b525b252472a8bc86ef88f0ee074
Publikováno v:
Swiss Medical Weekly, Vol 152, Iss 2122 (2022)
We report a case of recurrent tender, multifocal lymphadenopathies associated with B-symptoms, clinically mimicking lymphoma in a mRNA-1273 vaccine recipient after a recent Epstein-Barr virus (EBV) infection. In the lymph node biopsy, monocytoid B-
Externí odkaz:
https://doaj.org/article/8baa6de11b374d10b9b8abc1e8baba73
Autor:
Cédric Follonier, Elena Tessitore, Sandra Handgraaf, David Carballo, Maëlle Achard, Antoinette Pechère-Bertschi, François Mach, François R. Herrmann, François R. Girardin
Publikováno v:
PLoS ONE, Vol 17, Iss 11 (2022)
Aims To assess the associations of exposure and modifications in exposure (i.e., discontinuation on admission, initiation during hospitalization) to eight common cardiovascular therapies with the risk of in-hospital death among inpatients with corona
Externí odkaz:
https://doaj.org/article/6aa2407d51cf41cd81095b6ac8013519
Autor:
Antoine Poncet, Baris Gencer, Marc Blondon, Marianne Gex-Fabry, Christophe Combescure, Dipen Shah, Peter J Schwartz, Marie Besson, François R Girardin
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0127213 (2015)
IMPORTANCE:Sudden cardiac death is a leading cause of mortality in psychiatric patients. Long QT (LQT) is common in this population and predisposes to Torsades-de-Pointes (TdP) and subsequent mortality. OBJECTIVE:To estimate the cost-effectiveness of
Externí odkaz:
https://doaj.org/article/49a1fea6d9474c4784101e4f002016e9
Autor:
François R Girardin
Publikováno v:
PharmacoEconomics & Outcomes News. 822:30-30
Autor:
Vernaz, N., Haller, G., François R Girardin, Huttner, B., Dayer, P., Muscionico, D., Salomon, J. L., Bonnabry, P.
Publikováno v:
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d53715d3d9cb96ad9d01826647d81c1e
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000312411100073&KeyUID=WOS:000312411100073
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000312411100073&KeyUID=WOS:000312411100073
Autor:
Marie-Claude Addor, David Baud, Maya Berlin, Alice Panchaud, Thierry Buclin, François R Girardin, Ursula Winterfeld, Corinna Weber-Schoendorfer, Orna Diav-Citrin, Faiza Lamine, Kim Dao, Svetlana Shechtman, Reem Hegla Murad, Ariela Hazan, Jonathan L Richardson, Georgios Eleftheriou, Valentin Rousson, Leonore Diezi, David Haefliger, Ana Paula Simões-Wüst
Publikováno v:
BMJ Open, Vol 14, Iss 4 (2024)
Objectives Glucagon-like peptide 1 receptor agonists (GLP1-RA) are indicated for the treatment of type 2 diabetes and more recently for weight loss. The aim of this study was to assess the risks associated with GLP1-RA exposure during early pregnancy
Externí odkaz:
https://doaj.org/article/0d9228cc67e8424b806167a253009ff7